The Inflation Reduction Act will cap Medicare beneficiaries' annual out-of-pocket spending on prescription drugs at $2,000 starting in 2025, saving an average of $400 per year for those with Medicare. This provision is part of a larger effort to reduce healthcare costs and improve access to medication.